Source: finsmes.com

Vensica received $11M in Equity Funding

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

Founder & CEO

Avner Geva

CEO Approval Rating

90/100

Vensica is an Israel-based biopharmaceutical company that develops drugs and ultrasound catheters for the treatment of bladder cancer.